Search

everythinglearnresearchcommunity

for

Search:↓

Elderly patients frequently suffer from skin conditions, especially inflammatory ones, highlighting the need for better healthcare.

The FDA warned about safety issues with remdesivir and tofacitinib, finasteride is linked to suicidality, potent topical corticosteroids increase osteoporosis risk, henna can cause hemolysis in G6PD deficiency, chemotherapeutic agents can cause adverse reactions, drug interactions are common in cancer patients, ketamine can reduce at-risk drinking, high dose of anticholinergics increases dementia risk in Parkinson's patients, and prenatal exposure to second-generation antipsychotics increases pregnancy complications.

The model and estimator can predict drug exposure in kidney transplant patients well.

CRPS I is complex, linked to immune and nerve issues, and needs comprehensive treatment.

Natural products like propolis are causing more skin allergies, and certain skin treatments and medications have various side effects and risks.

Topical metformin may improve hair regrowth in CCCA when added to standard treatments.

Experts recommend personalized treatment plans for alopecia areata, using corticosteroids and minoxidil for mild cases, and stronger medications for severe cases.

Ritlecitinib is effective and safe for treating severe alopecia areata in people aged 12 and older.

Botulinum A toxin injections reduced pain and promoted hair regrowth in a woman with a rare form of alopecia areata.

Telogen effluvium is a common hair loss condition requiring careful diagnosis and treatment.

Trichoscopy helps tell apart other hair loss conditions from common hair loss.

Brepocitinib effectively reduces inflammation and improves symptoms in cicatricial alopecia with good safety.

A patient developed nerve problems as a side effect of a hair loss treatment called tofacitinib.

Accurate diagnosis is crucial for effective treatment of hair loss.

Treating primary cicatricial alopecia is difficult and requires evidence-based methods.

The document concludes that different types of permanent hair loss conditions are related and early treatment is key to preventing further damage.

Dermoscopy helps accurately diagnose temporal triangular alopecia, avoiding unnecessary treatments.

Ritlecitinib is safe and may effectively treat alopecia areata.

Endoscopic brow-lift is effective and well-tolerated, with high patient satisfaction and improved appearance.

Alopecia Areata causes hair loss and needs treatments that address both physical and emotional health.

Botulinum toxin is not effective for treating male hair loss.

Younger people are at a higher risk for Fibrosing Alopecia in a Pattern Distribution than previously thought, with common symptoms and possible involvement of mast cells in its development.

Bicalutamide can reduce female pattern hair loss, especially in those with certain conditions, but has limited effects on other hair loss types.

Telogen Effluvium causes increased hair shedding and can be challenging to diagnose and treat.

Thallium, mercury, selenium, and colchicine strongly cause hair loss.

The procedure safely and effectively lifted the lateral brow, improving appearance with minimal complications.

Long COVID-19 patients with skin pain might have a nerve condition that responds to a medication called gabapentin.

Losartan may help treat Postural Orthostatic Tachycardia Syndrome (POTS) symptoms.

Wigs help improve self-esteem and quality of life for people with hair loss from alopecia areata.

A woman's progressive hair loss was correctly diagnosed as a rare condition called fibrosing alopecia in a pattern distribution after initially being mistaken for a more common type.